Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= antirheumatic agents
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(10)
+
-
Availability
Open access
(9)
+
-
Metadata Only
(1)
+
-
Creation Date
2021
(7)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Scholarly Publications
(2)
+
-
Topic
antirheumatic agents
(10)
+
-
arthritis
(4)
+
-
rheumatoid
(3)
+
-
therapeutics
(3)
+
-
COVID-19
(2)
+
-
ankylosing
(2)
+
-
epidemiology
(2)
+
-
glucocorticoids
(2)
+
-
rheumatoid arthritis
(2)
+
-
spondylitis
(2)
+
-
Show more
Author
Heijde, D. van der
(5)
+
-
Landewe, R.B.M.
(5)
+
-
Baraliakos, X.
(2)
+
-
Bartok, B.
(2)
+
-
Bergstra, S.A.
(2)
+
-
Deodhar, A.
(2)
+
-
Guo, Y.
(2)
+
-
Jahreis, A.
(2)
+
-
Machado, P.M.
(2)
+
-
Matzkies, F.
(2)
+
-
Mozaffarian, N.
(2)
+
-
Sundy, J.S.
(2)
+
-
Tanaka, Y.
(2)
+
-
Tasset, C.
(2)
+
-
Show more
Language
en
(10)
+
-
Search results
(1 - 10 of 10)
show grid
show list
save search
Initial glucocorticoid bridging in rheumatoid arthritis
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
Effects of denosumab in Japanese patients with rheumatoid arthritis treated with conventional antirheumatic drugs
Tofacitinib for the treatment of ankylosing spondylitis
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate
COVID-19-induced hyperinflammation, immunosuppression, recovery and survival
S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease